Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane
article
OA: bronze
CC0
⤵ 62 in-corpus citations
AI-generated summary
Angiostatic agents were tested and found to prevent the formation of endometriosis-like lesions on the chicken chorioallantoic membrane.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (10)
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane via openalex
- W2060449870 via openalex
- W2017556192 via openalex
- W2144543824 via openalex
- W2131798870 via openalex
- W2010435021 via openalex
Cited by (50)
- Transgenic mice applications in the study of endometriosis pathogenesis 2024
- Strategies for modelling endometrial diseases 2022
- Effects of ranibizumab and zoledronic acid on endometriosis in a rat model 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Endometriosis Research: From Bench to Bedside 2022
- Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects 2022
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Effects of ranibizumab and zoledronic acid on endometriosis in a rat model 2021
- Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report 2021
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
- Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology 2020
- In‑vitro models of human endometriosis (Review) 2019
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
- Endometriosis — insights into a multifaceted entity 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Experimental endometriosis models: different approaches for different tasks 2016
- Endometriosis: where are we and where are we going? 2016
- Epidemiology of subtle, typical, cystic, and deep endometriosis: a systematic review 2016
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- Treatment of Endometriosis with Non-Hormonal Agents: Review 2016
- Non‐hormonal targets underlying endometriosis: A focus on molecular mechanisms 2015
- Novel Medical Treatment Modalities of Endometriosis 2015
- Endometriosis: alternative methods of medical treatment 2015
- Experimental Treatments of Endometriosis 2015
- An overview of early drug development for endometriosis 2015
- Novel agents for the medical treatment of endometriosis 2014
- Antiangiogenesis Therapy of Endometriosis Using PAMAM as a Gene Vector in a Noninvasive Animal Model 2014
- Comparative evaluation of vascular endothelial growth factor-A expression in pre-ovulatory follicular fluid in normogonadotrophic and endometriotic patients undergoing assisted reproductive techniques 2013
- Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. 2013
- Slit2 Overexpression Results in Increased Microvessel Density and Lesion Size in Mice With Induced Endometriosis 2012
- Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- Antiangiogenic agents for endometriosis 2011
- Models of Endometriosis:<i>In vitro</i>and<i>In vivo</i>Models 2011
- Angiogenesis and Endometriosis 2011
- Diagnosis of Endometriosis: Imaging 2011
- The emerging role of epigenetics in the aetiology of endometriosis. 2011
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis 2011
- The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model 2011
- Theories on the Pathogenesis of Endometriosis 2011
- Evolving Spectrum: 2010
- In Vitro Models to Study the Pathogenesis of Endometriosis 2009
- Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model 2009
- Doxycycline causes regression of endometriotic implants: a rat model 2009
- Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue 2009
- Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises 2008
- Emerging drugs for endometriosis 2008
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:41.664291+00:00
License: CC0
· commercial use OK